“Medicinal cannabis” is defined as the use of cannabis-based products for the treatment of
an illness. Investigations of cannabis compounds in psychiatric and neurological illnesses …

Background Impairment in a wide range of cognitive abilities has been consistently reported
in individuals with schizophrenia. Both neurocognitive and social cognitive deficits are …

Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

Access to cannabis and cannabinoid products is increasing worldwide for recreational and
medicinal use. Two primary compounds within cannabis plant matter, Δ 9 …

Movement disorders such as Parkinson's disease and dyskinesia are highly debilitating
conditions linked to oxidative stress and neurodegeneration. When available, the …

Cannabis sativa L. is a plant long used for its textile fibers, seed oil, and oleoresin with
medicinal and psychoactive properties. It is the main source of phytocannabinoids, with over …

Background: Cannabis is the most widely used illicit substance worldwide, and legalization
for recreational and medical purposes has substantially increased its availability and use in …

Abstract Purpose of Review The lack of clarity about the effect of cannabis use on cognition
may be attributable to the considerable heterogeneity among studies in terms of cannabis …

Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …

Introduction: Chronic cannabis use has been associated with impaired cognition and
elevated psychological symptoms, particularly psychotic-like experiences. While Δ9 …